SYLVESTER, Richard

Full Name
SYLVESTER, Richard
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  de Mulder, P.H.M.

Results 1-5 of 5 (Search time: 0.006 seconds).

Issue DateTitleContributor(s)TypeCat.
11999Impact of the treating institution on survival of patients with "poor progosis" metastatic nonseminomaCollette, L.; SYLVESTER, Richard; Stenning, S.P.; Fossa, S.D.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Neymark, N.; Lallemand, E.; Kaye, S.B.Journal Contribution
21998Serum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceSYLVESTER, Richard; de Wit, R.; Collette, L.; de Mulder, P.H.M.; Sleijfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.Journal Contribution
31997Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer TrialHorwich, A.; Sleijfer, D.T.; Fossa, S.D.; Kaye, S.B.; Oliver, R.T.D.; Cullen, M.H.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Dearnaley, D.P.; Cook, P.A.; Stenning, S.P.; SYLVESTER, RichardJournal Contribution
41997Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancerde Wit, R.; SYLVESTER, Richard; Tsitsa, C.; de Mulder, P.H.M.; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.Journal Contribution
51995EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinomade Mulder, P.H.M.; Oosterhof, G.O.N.; Bouffioux, Christophe; van Oosterom, A.T.; Vermeylen, K.; SYLVESTER, RichardJournal Contribution